100 labs in 36 states are set up to run the fast, low-cost, saliva-based testing. A Yale team hopes to make the protocol available to as many labs as possible.
By Mike Cummings
March 1, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
Joshua Narcisse ’19 M.Div., G. Scott Morris ’79 M.Div, and Rev. Jason Turner ’06 M.Div.
In 1987, G. Scott Morris ’79 M.Div. founded Church Health, a non-profit organization that provides healthcare services to uninsured and underserved people in Memphis, Tennessee, and its suburbs. He’s built it into the nation’s largest privately funded, faith-based health service, providing comprehensive medical care to tens of thousands of people, with a full-time staff of 20 physicians and more than 1,000 doctors who volunteer.
When the COVID-19 pandemic struck, Morris knew that the support of the city’s vibrant faith community including Church Health was essential to checking the virus’ spread. Local faith leaders have the trust of their congregations, he said, making them indispensable in building support for public-health measures, such
March 2, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
Dr. Stuart H. Orkin
The 2021 Gruber Genetics Prize has been awarded to Harvard hematologist-oncologist and geneticist Dr. Stuart H. Orkin for his pioneering discoveries of the genetic underpinnings of blood disorders. His remarkable body of work has not only revolutionized our understanding of how these illnesses occur but has also led to promising new gene-based therapies for thalassemia and sickle cell disease, two inherited blood disorders that affect millions of people around the world.
Orkin is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School and the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, and an investigator of the Howard Hughes Medical Institute.
By Bill Hathaway
March 2, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
When central nervous system cells in the brain and spine are damaged by disease or injury, they fail to regenerate, limiting the body’s ability to recover. In contrast, peripheral nerve cells that serve most other areas of the body are more able to regenerate. Scientists for decades have searched for molecular clues as to why axons the threadlike projections which allow communication between central nervous system cells cannot repair themselves after stroke, spinal cord damage, or traumatic brain injuries.
In a massive screen of 400 mouse genes, Yale School of Medicine researchers have identified 40 genes actively involved in suppression of axon regeneration in central nervous system cells. By editing out one of those genes, they were able to restore axons in ocular nerves of mice damaged by glaucoma.